Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000905148-25-000399
Filing Date
2025-02-06
Accepted
2025-02-06 16:16:36
Documents
2
Period of Report
2025-02-01

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 6177
2 poa.htm EX-24 7287
  Complete submission text file 0000905148-25-000399.txt   14869
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Issuer) CIK: 0001661059 (see all company filings)

EIN.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 9000 VIRGINIA MANOR ROAD SUITE 200 BELTSVILLE MD 20705
Business Address
Guha Udayan (Reporting) CIK: 0002054923 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38905 | Film No.: 25597598